Evidence map›Paper›PMID 28710683›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2017

Highly selective CB

M Salaga, H Zatorski, M Zielińska, P Mosinska, J-P Timmermans, R Kordek, M Storr, J Fichna

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Efficiency and Mechanism Evaluation ofEvidence-based complementary and alternative medicine : eCAM · 2023
    Article
  2. Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

M SalagaDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 6/8, 92-215, Lodz, Poland.
H ZatorskiDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 6/8, 92-215, Lodz, Poland.
M ZielińskaDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 6/8, 92-215, Lodz, Poland.
P MosinskaDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 6/8, 92-215, Lodz, Poland.
J-P TimmermansLaboratory of Cell Biology and Histology, Department of Veterinary Sciences, University of Antwerp, Antwerp, Belgium.
R KordekDepartment of Pathology Faculty of Medicine, Medical University of Lodz, Lodz, Poland.
M StorrDepartment of Medicine, Division of Gastroenterology, Ludwig Maximilians University of Munich, Munich, Germany.
J FichnaDepartment of Biochemistry, Faculty of Medicine, Medical University of Lodz, Mazowiecka 6/8, 92-215, Lodz, Poland. jakub.fichna@umed.lodz.pl.
Medical University of Lodz · PLLudwig-Maximilians-Universität München · DEUniversity of Antwerp · BE

Funding

Narodowe Centrum Nauki UMO-2013/11/N/NZ7/00724Narodowe Centrum Nauki UMO-2013/11/N/NZ7/02354Narodowe Centrum Nauki (PL) UMO-2013/11/B/NZ7/01301 and UMO-2014/13/B/NZ4/01179Polish Ministry of Science and Higher Education 0202/DIA/2015/44Polish Ministry of Science and Higher Education IP2015068774Uniwersytet Medyczny w Lodzi 502-03/1-156-04/502-14-298Uniwersytet Medyczny w Lodzi 503/1-156-04/503-11-001Uniwersytet Medyczny w Lodzi (PL) 502-03/1-156-02/502-14-141
6 · The paper itself

Abstract

Cannabinoid type 2 (CB

Indexed as

AnimalsAnti-Ulcer AgentsGastric MucosaInflammation MediatorsMaleMiceMice, Inbred BALB CProtective AgentsReceptor, Cannabinoid, CB2Stomach UlcerThiazolesTreatment OutcomeA-836339Anti-Ulcer AgentsInflammation MediatorsProtective AgentsReceptor, Cannabinoid, CB2ThiazolesCB2 receptorsEndocannabinoid systemGastric ulcerOxidative stress

Identifiers

PMID28710683
OpenAlexW2735448676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.